Literature DB >> 33732601

Review of nanotheranostics for molecular mechanisms underlying psychiatric disorders and commensurate nanotherapeutics for neuropsychiatry: The mind knockout.

Rajiv Kumar1, Bhupender S Chhikara2, Kiran Gulia3, Mitrabasu Chhillar4.   

Abstract

Bio-neuronal led psychiatric abnormalities transpired by the loss of neuronal structure and function (neurodegeneration), pro-inflammatory cytokines, microglial dysfunction, altered neurotransmission, toxicants, serotonin deficiency, kynurenine pathway, and excessively produced neurotoxic substances. These uncontrolled happenings in the etiology of psychiatric disorders initiate further changes in neurotransmitter metabolism, pathologic microglial, cell activation, and impaired neuroplasticity. Inflammatory cytokines, the outcome of dysfunctional mitochondria, dysregulation of the immune system, and under stress functions of the brain are leading biochemical factors for depression and anxiety. Nanoscale drug delivery platforms, inexpensive diagnostics using nanomaterials, nano-scale imaging technologies, and ligand-conjugated nanocrystals used for elucidating the molecular mechanisms and foremost cellular communications liable for such disorders are highly capable features to study for efficient diagnosis and therapy of the mental illness. These theranostic tools made up of multifunctional nanomaterials have the potential for effective and accurate diagnosis, imaging of psychiatric disorders, and are at the forefront of leading technologies in nanotheranostics openings field as they can collectively and efficiently target the stimulated territories of the cerebellum (cells and tissues) through molecular-scale interactions with higher bioavailability, and bio-accessibility. Specifically, the nanoplatforms based neurological changes are playing a significant role in the diagnosis of psychiatric disorders and portraying the routes of functional restoration of mental disorders by newer imaging tools at nano-level in all directions. Because of these nanotherapeutic platforms, the molecules of nanomedicine can penetrate the Blood-Brain Barrier with an increased half-life of drug molecules. The discoveries in nanotheranostics and nanotherapeutics inbuilt unique multi-functionalities are providing the best multiplicities of novel nanotherapeutic potentialities with no toxicity concerns at the level of nano range. © The author(s).

Entities:  

Keywords:  Psychiatric disorders; and kynurenine pathway; microglial dysfunction; nanotheranostics; nanotherapeutics; neurodegeneration; pro-inflammatory cytokines

Year:  2021        PMID: 33732601      PMCID: PMC7961125          DOI: 10.7150/ntno.49619

Source DB:  PubMed          Journal:  Nanotheranostics        ISSN: 2206-7418


  112 in total

Review 1.  [Inflammatory cytokines].

Authors:  Hideto Ishii; Masayuki Yoshida
Journal:  Nihon Rinsho       Date:  2010-05

Review 2.  Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases.

Authors:  Denzil Furtado; Mattias Björnmalm; Scott Ayton; Ashley I Bush; Kristian Kempe; Frank Caruso
Journal:  Adv Mater       Date:  2018-07-31       Impact factor: 30.849

Review 3.  Multifunctional DNA Origami Nanoplatforms for Drug Delivery.

Authors:  Xuehe Lu; Jianbing Liu; Xiaohui Wu; Baoquan Ding
Journal:  Chem Asian J       Date:  2019-06-17

4.  Failures of metacognition and lack of insight in neuropsychiatric disorders.

Authors:  Anthony S David; Nicholas Bedford; Ben Wiffen; James Gilleen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-05-19       Impact factor: 6.237

Review 5.  Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease.

Authors:  Gary Fiskum; Anatoly Starkov; Brian M Polster; Christos Chinopoulos
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

Review 6.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 7.  Schizotypal personality disorder: a current review.

Authors:  Daniel R Rosell; Shira E Futterman; Antonia McMaster; Larry J Siever
Journal:  Curr Psychiatry Rep       Date:  2014-07       Impact factor: 5.285

8.  The Case for Adaptive Neuromodulation to Treat Severe Intractable Mental Disorders.

Authors:  Nicole R Provenza; Evan R Matteson; Anusha B Allawala; Adriel Barrios-Anderson; Sameer A Sheth; Ashwin Viswanathan; Elizabeth McIngvale; Eric A Storch; Michael J Frank; Nicole C R McLaughlin; Jeffrey F Cohn; Wayne K Goodman; David A Borton
Journal:  Front Neurosci       Date:  2019-02-26       Impact factor: 4.677

Review 9.  Neuroinflammation: friend and foe for ischemic stroke.

Authors:  Richard L Jayaraj; Sheikh Azimullah; Rami Beiram; Fakhreya Y Jalal; Gary A Rosenberg
Journal:  J Neuroinflammation       Date:  2019-07-10       Impact factor: 8.322

Review 10.  Brain age and other bodily 'ages': implications for neuropsychiatry.

Authors:  James H Cole; Riccardo E Marioni; Sarah E Harris; Ian J Deary
Journal:  Mol Psychiatry       Date:  2018-06-11       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.